Ablation Falls Short in Oligometastatic Breast Cancer Trial
Ablation Falls Short in Oligometastatic Breast Cancer Trial Medscape
Онкология
Рак молочной железы
677 материалов по теме, собраны автоматически из проверенных источников
Онкология
How Breast Cancer Cells Cope With Stress Points to Potential Drug Target
How Breast Cancer Cells Cope With Stress Points to Potential Drug Target Technology Networks
Онкология
В больницу № 5 Уфы поступил новый маммограф
В больницу № 5 Уфы поступил новый маммограф ГТРК «Башкортостан
🎗️
Онкология
Endeavor joins breast cancer research consortium, adding suburban reach
Endeavor joins breast cancer research consortium, adding suburban reach Crain's Chicago Business
Онкология
JMIR Cancer Opens Call for Breast Cancer Research to Mark Awareness Month
JMIR Cancer Opens Call for Breast Cancer Research to Mark Awareness Month Bioengineer.org
Онкология
FDA Approves Tukysa Maintenance Treatment for HER2-Positive Metastatic Breast Cancer
FDA Approves Tukysa Maintenance Treatment for HER2-Positive Metastatic Breast Cancer WebMD
Онкология
Endeavor Health joins Chicago Breast Cancer Research Consortium
Endeavor Health joins Chicago Breast Cancer Research Consortium Evanston RoundTable
Онкология
Automated breast ultrasound is effective alternative to handheld ultrasound for breast cancer screening, study finds
A new study in the Journal of the American College of Radiology has found that automated breast ultrasound (ABUS) and handheld ultrasound (HHUS) had similar cancer detection rates in women with dense breasts, while ABUS had a lower false-positive rate. The study demonstrates that ABUS is a viable alternative to HHUS…
Онкология
Finding meaning in my stage 3 triple-negative breast cancer diagnosis
Finding meaning in my stage 3 triple-negative breast cancer diagnosis UT MD Anderson
Онкология
JMIR Publications’ JMIR Cancer invites submissions on breast cancer
JMIR Publications’ JMIR Cancer invites submissions on breast cancer EurekAlert! Science News Releases
Онкология
Pfizer Tukysa Regimen Gets FDA Nod for Maintenance Treatment of HER2+ Metastatic Breast Cancer
Pfizer Tukysa Regimen Gets FDA Nod for Maintenance Treatment of HER2+ Metastatic Breast Cancer Contract Pharma
Онкология
Endeavor Health joins multi-institution Chicago Breast Cancer Research Consortium
Endeavor Health joins multi-institution Chicago Breast Cancer Research Consortium CBS News
Онкология
Randomized trial finds targeting individual metastases in oligometastatic breast cancer does not improve survival
Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall survival for patients with oligometastatic breast cancer receiving first-line systemic therapy, according to results from the randomized NRG-BR002 clinical trial led by researchers at The…
Онкология
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Nova Scotia
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Nova Scotia Yahoo Finance
Онкология
Tukysa Wins FDA Nod for First-Line HER2-Positive Breast Cancer Maintenance After Trial Showed 8.6-Month Longer Median Disease Control
Tukysa Wins FDA Nod for First-Line HER2-Positive Breast Cancer Maintenance After Trial Showed 8.6-Month Longer Median Disease Control Medical Daily